Benton Bodamer

Practice Areas

Benton Bodamer is Practice Group Chair - Corporate, Private Equity, M&A. He has represented a wide range of public and private companies, as well as many of the leading international private equity sponsors.

He regularly advises clients on complex domestic and cross-border mergers and acquisitions, leveraged buyouts, joint ventures, minority investments, divestitures, and restructurings. Mr. Bodamer also routinely counsels privately held businesses (including sponsor portfolio companies) on general corporate matters, governance, corporate best practices, and commercial transactions.

Professional Memberships

Adjunct Professor, The Ohio State University Moritz College of Law, working with the College’s Drug Enforcement & Policy Center

Publications

Co-Author, “U.S. Treasury Department Suspends Enforcement of Corporate Transparency Act for U.S. Citizens and U.S. Companies,” Dickinson Wright Client Alert, March 2025; Co-Author, "Cliffs Without Fences and Fences Without Cliffs: Exploring the Emerging Conflicts Between Quasi-Legal Intoxicating Hemp and Regulated State-Legal Cannabis," Ohio State Legal Studies Research Paper, No. 855, Drug Enforcement and Policy Center, June 2024; Co-Author, "At the Intersection of Law and Technology: Navigating Generative AI in the Legal Industry Part 2," Texas Lawyer, March 2024; Co-Author, "Artificial Incompetence: How Generative AI Creates Latent Intellectual Property Issues," The Journal of Robotics, Artificial Intelligence & Law, March 2024; Author, “A Prescription for Progress? Would a Schedule III Reclassification of Psychoactive Cannabis Help or Hurt State Operators?” Ohio State Legal Studies Research Paper, No. 799, Drug Enforcement and Policy Center No. 72, September 2023.

Education

Awards